The boxing world has been rocked by recent revelations that Alycia Baumgardner, the undisputed women’s junior lightweight world champion, tested positive for the banned steroid mesterolone. This information emerged after her triumph over Christina Linardatou on July 15, with Fight Freaks Unite revealing the details.
Matchroom Boxing, the promoter behind the event, responded swiftly. They confirmed the adverse findings and reiterated their dedication to ensuring the integrity of the sport. Their statement elaborated on their commitment to fairness and ensuring all athletes compete cleanly. While awaiting further details, they assured full support to Baumgardner during the investigation, refraining from any more comments.
Baumgardner’s victory against Linardatou at The Masonic Temple in Detroit was significant. The scores, 100-90, 98-92, and 97-93, reflected her dominance in the bout. Following this win, there was a lot of buzz about Baumgardner potentially stepping into the ring against champions like Amanda Serrano, heightening her status in the boxing circuit.
Yet, these drug test results cast a pall over her achievements. It remains to be seen how this controversy will impact her future bouts and potential matchups. As the boxing community eagerly awaits further developments, Baumgardner’s career hangs in the balance.
Image Credit: Sky Sports